VOLUME 53 | NUMBER 6 | DECEMBER 2018
The Case for Restructuring the Medicare Prescription Drug Benefit
Implemented a dozen years ago, the Medicare's prescription drug benefit (Part D) has outgrown its initial design and is in need of restructuring. Created as a public–private partnership, clear signs have emerged that changes in the market and private firms’ responses to incentives in the Part D reinsurance program act to inefficiently increase government expenditures. However, a few reforms could shrink this source of waste while protecting and supporting aspects of the program that benefit enrollees.
Copyright© 2018, Health Research & Educational Trust. All rights reserved. Content Disclaimer
Health Research & Educational Trust, 155 North Wacker, 4th Floor Chicago, IL 60606 (312) 422.2600